Holen Sie sich die Stockscreener-App
175.34
0.00%
0.00
Handel nachbörslich:
175.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Becton Dickinson Sues Baxter Over Infusion Pump Patents - Law360
Transcript : Becton, Dickinson and Company Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com
Becton Dickinson at Bank of America Conference: Navigating Challenges and Opportunities - Investing.com
Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News
Sterile Lancets Market Set to Grow | Key Players: Roche, Becton Dickinson, Medtronic - openPR.com
Becton Dickinson (BDX) Unveils Advanced Cell Analyzer - GuruFocus
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies - marketscreener.com
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Becton Dickinson & Co (BDX) Shares Up 3.73% on May 12 - GuruFocus
Becton Dickinson, Spotify, Arvinas, Twilio, Lumen: Trending by Analysts - MSN
The Strong Earnings Posted By Becton Dickinson (NYSE:BDX) Are A Good Indication Of The Strength Of The Business - Yahoo
Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.
Judge declares mistrial in punitive damages phase in Walker v. BD - The Covington News
Becton, Dickinson downgraded at more firms following Q2 results - MSN
Becton Dickinson downgraded to Neutral from Buy at Goldman Sachs - MSN
Jim Cramer on Becton, Dickinson and Company (BDX): “A Shocking Miss for This Once-Reliable Med Tech Giant” - Insider Monkey
Mistrial declared after jury awards $50M in landmark toxic gas case - AJC.com
Becton Dickinson (NYSE:BDX) Sees 18% Price Dip Over Last Week - Yahoo Finance
Becton Dickinson (BDX) Price Target Lowered by Morgan Stanley | BDX Stock News - GuruFocus
Investors Can Still File Late Claims for Becton, Dickinson & Co $85M Settlement Payouts - TradingView
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $196 From $280, Maintains Overweight Rating - marketscreener.com
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton, Dickinson, and Company (BDX): Among the Best Falling Stocks to Buy According to Analysts - Insider Monkey
Piper Sandler Downgrades Becton, Dickinson and (WBAG:BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Q2 2025 Earnings Call Transcript - Insider Monkey
William Blair Downgrades Becton, Dickinson and (XTRA:BOX) - Nasdaq
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years - Benzinga
Jefferies cuts Becton Dickinson target to $255, maintains Buy By Investing.com - Investing.com Nigeria
Raymond James cuts Becton Dickinson stock rating to Market Perform By Investing.com - Investing.com Nigeria
Becton, Dickinson Shares Drop After Multiple Analyst Downgrades - marketscreener.com
Becton Dickinson (BDX) Faces Downgrades Amid Growth Concerns - GuruFocus
Goldman Sachs cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Becton Dickinson downgraded to Neutral from Overweight at Piper Sandler - TipRanks
Becton Dickinson (BDX) Sees Downgrade and Price Target Cut by Piper Sandler | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Rating Maintained by Stifel, Price Target Lowered | BDX Stock News - GuruFocus
Wall Street analysts downgrade Becton Dickinson & Co. as ’confidence eroded’ - Investing.com
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg.com
Becton Dickinson (BDX) Faces Downgrade Amid Growth and Tariff Co - GuruFocus
Jefferies cuts Becton Dickinson target to $255, maintains Buy - Investing.com
Raymond James cuts Becton Dickinson stock rating to Market Perform - Investing.com
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BD - GuruFocus
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lo - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lowered | BDX Stock News - GuruFocus
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: St - GuruFocus
Piper Sandler cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Goldman Sachs cuts Becton Dickinson stock rating to neutral - Investing.com
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid ... - Yahoo Finance
Becton, Dickinson Reports Q2 2025 Earnings Growth - TipRanks
Becton Dickinson (BDX) Downgraded to Market Perform by William B - GuruFocus
Becton Dickinson: Fiscal Q2 Earnings Snapshot - CT Insider
Becton Dickinson (BDX) Price Target Cut Amid Disappointing FY25 Outlook | BDX Stock News - GuruFocus
Stifel cuts Becton Dickinson target to $224, maintains buy By Investing.com - Investing.com Nigeria
Becton Dickinson (BDX) Faces Downgrades After Revised Earnings F - GuruFocus
Becton Dickinson (BDX) Downgraded by BofA Following Missed Growt - GuruFocus
Becton Dickinson (BDX) Unveils Strategic Investments Amid Q2 Rev - GuruFocus
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit - MSN
Stifel cuts Becton Dickinson target to $224, maintains buy - Investing.com
BofA downgrades Becton Dickinson to Neutral on ‘inconsistent execution’ - TipRanks
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):